ClinicalTrials.Veeva

Menu

Comparison of Somofilcon A Daily Disposable Test Contact Lens and Somofilcon A Daily Disposable Control Contact Lens

CooperVision logo

CooperVision

Status

Completed

Conditions

Myopia

Treatments

Device: somofilcon A 1 day control lens
Device: somofilcon A 1 day test lens

Study type

Interventional

Funder types

Industry

Identifiers

NCT03372551
CV-16-43

Details and patient eligibility

About

The purpose of this study is to investigate the overall clinical performance of the somofilcon A daily disposable test soft contact lens compared to the somofilcon A daily disposable control soft contact lens.

Full description

The purpose of this study is to evaluate the clinical performance of an investigational silicone-hydrogel contact lens (test) against a marketed silicone-hydrogel contact lens (control) when worn on a daily disposable wear modality over 1 week (for each lens) in a randomized, bilateral, cross-over, dispensing study.

Enrollment

36 patients

Sex

All

Ages

17+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Is at least 17 years of age and has full legal capacity to volunteer;
  • Has had a self-reported oculo-visual examination in the last two years;
  • Has read, understood, and signed the information consent letter;
  • Is willing and able to follow instructions and maintain the appointment schedule;
  • Has a visual acuity of 20/30 or better (in each eye) with their habitual vision correction, or 20/20 best-corrected vision (for binocular distance acuity);
  • Must be able to achieve 20/30 or better (in each eye) with the study lenses;
  • Currently wears soft contact lenses for at least 3 days per week, 8 hours each day;
  • Requires spectacle lens powers between -0.75 and -06.50 diopters sphere (0.25D steps);
  • Has no more than 0.75 diopters of refractive astigmatism;
  • Has clear corneas and no active* ocular disease;
  • Has not worn lenses for at least 12 hours before the examination.

Exclusion criteria

  • Is presently participating in any other clinical or research study including eye related clinical or research study;
  • Has never worn contact lenses before.
  • Has any systemic disease affecting ocular health.
  • Has any active* ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
  • Is using any systemic or topical medications that will affect a study outcome variable, and/or ocular health.
  • Has any known sensitivity to fluorescein dye or products to be used in the study.
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
  • Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
  • Is aphakic.
  • Has undergone corneal refractive surgery.
  • Is pregnant, lactating, or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

36 participants in 2 patient groups

somofilcon A 1 day test lens
Experimental group
Description:
Subjects wearing the somofilcon A 1 day test lens for one week, either randomized as the first or second pair.
Treatment:
Device: somofilcon A 1 day test lens
Device: somofilcon A 1 day control lens
somofilcon A 1 day control lens
Active Comparator group
Description:
Subjects wearing the somofilcon A 1 day control lens for one week, either randomized as the first or second pair.
Treatment:
Device: somofilcon A 1 day test lens
Device: somofilcon A 1 day control lens

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems